Summary

sheetzoo5 Users

  • Targeted immunotherapy regarding HER2-low breast cancer with 17p damage.
Offline Offline
Posts:
0 (0 per day)
Age:
N/A
Date Registered:
2025-07-14, 14:09:00
Local Time:
2025-07-18, 06:02:47
Last Active:
2025-07-14, 20:04:06
Signature:
10 (1.03-1.17) at 30 years, 1.11 (1.04-1.17) at 50 years and 1.19 (1.10-1.29) at baseline. The results for women were similar with multivariable RR of